Welcome to our dedicated page for CAPVX news (Ticker: CAPVX), a resource for investors and traders seeking the latest updates and insights on CAPVX stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CAPVX's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CAPVX's position in the market.
Calamos and Aksia have announced the launch of the Calamos Aksia Private Equity & Alternatives Fund (CAPVX), marking a significant expansion of their strategic partnership. The fund, which debuts on July 1, 2025, aims to democratize access to private equity investments through an innovative interval fund structure.
CAPVX enters the market with an established track record, having achieved a 25.5% return over nine months through April 30, 2025, outperforming the MSCI World index. The fund focuses on small and middle market co-investments and specialized secondaries, offering daily purchases and semi-annual liquidity. Notable features include a fee structure of 1.25% for the first year and 1.75% thereafter, with no incentive fees.
The launch coincides with the introduction of AC Private Markets, a new brand uniting Calamos and Aksia's expertise in liquid and institutional alternatives, respectively. The fund builds on the success of their previous offering, CAPIX, and aims to provide institutional-quality private market opportunities to a broader investor base, including non-accredited investors.
